NCT06757569 · RECRUITING

Radialis PET Imager for the Assessment of Neuritic Amyloid Plaque Burden

This trial tests whether a smaller, portable PET scanner called the Radialis PET Imager can produce brain amyloid images that are as clear and accurate as those from a standard PET/CT or PET/MRI machine. Participants already scheduled for a routine amyloid PET scan simply stay a bit longer for a second scan on the new device. This is a device-comparison study, not a drug trial, and the intervention itself is not experimental treatment.

Eligibility criteria

Inclusion Criteria:
1. Age ≥18 years
2. Patients with cognitive impairment undergoing the standard of care brain 18F-Florbetaben PET imaging.
3. Patients who can remain still for an additional scan of approximately 30-45 minutes.
   -
   Exclusion Criteria:
1. Inability to provide informed consent. 2. Contraindication for PET examination as per institutional safety guidelines, including but not limited to pregnancy or inability to remain still for PET examination.
-

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-02-03

View full record on ClinicalTrials.gov

All APOE4 clinical trials